GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (XTER:JNJ) » Definitions » Cyclically Adjusted FCF per Share

Johnson & Johnson (XTER:JNJ) Cyclically Adjusted FCF per Share : €0.00 (As of Mar. 2025)


View and export this data going back to 1996. Start your Free Trial

What is Johnson & Johnson Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Johnson & Johnson's adjusted free cash flow per share for the three months ended in Mar. 2025 was €1.284. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.00 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Johnson & Johnson's average Cyclically Adjusted FCF Growth Rate was 3.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 5.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 6.50% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Johnson & Johnson was 18.20% per year. The lowest was 4.50% per year. And the median was 9.70% per year.

As of today (2025-04-25), Johnson & Johnson's current stock price is €136.32. Johnson & Johnson's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was €0.00. Johnson & Johnson's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Johnson & Johnson was 27.31. The lowest was 17.69. And the median was 23.28.


Johnson & Johnson Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Johnson & Johnson's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Cyclically Adjusted FCF per Share Chart

Johnson & Johnson Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.99 6.13 6.96 7.02 7.71

Johnson & Johnson Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.28 7.39 7.10 7.71 -

Competitive Comparison of Johnson & Johnson's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Cyclically Adjusted Price-to-FCF falls into.


;
;

Johnson & Johnson Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Johnson & Johnson's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1.284/134.9266*134.9266
=1.284

Current CPI (Mar. 2025) = 134.9266.

Johnson & Johnson Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 1.491 100.684 1.998
201509 1.698 100.392 2.282
201512 1.219 99.792 1.648
201603 0.496 100.470 0.666
201606 1.213 101.688 1.609
201609 1.479 101.861 1.959
201612 1.906 101.863 2.525
201703 0.799 102.862 1.048
201706 1.650 103.349 2.154
201709 1.678 104.136 2.174
201712 1.499 104.011 1.945
201803 0.875 105.290 1.121
201806 1.637 106.317 2.078
201809 1.713 106.507 2.170
201812 1.588 105.998 2.021
201903 0.947 107.251 1.191
201906 1.680 108.070 2.098
201909 2.306 108.329 2.872
201912 1.730 108.420 2.153
202003 0.926 108.902 1.147
202006 0.929 108.767 1.152
202009 2.432 109.815 2.988
202012 2.161 109.897 2.653
202103 1.068 111.754 1.289
202106 1.398 114.631 1.646
202109 2.397 115.734 2.794
202112 1.430 117.630 1.640
202203 1.148 121.301 1.277
202206 1.673 125.017 1.806
202209 2.024 125.227 2.181
202212 1.339 125.222 1.443
202303 0.858 127.348 0.909
202306 1.075 128.729 1.127
202309 2.397 129.860 2.491
202312 2.189 129.419 2.282
202403 1.079 131.776 1.105
202406 1.786 132.554 1.818
202409 2.120 133.029 2.150
202412 1.902 133.157 1.927
202503 1.284 134.927 1.284

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Johnson & Johnson  (XTER:JNJ) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Johnson & Johnson was 27.31. The lowest was 17.69. And the median was 23.28.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Johnson & Johnson Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson Business Description

Industry
Address
One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.